<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mollon J</submitter><funding>NICHD NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><pagination>591-600</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10409883</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>94(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Our understanding of the impact of copy number variants (CNVs) on psychopathology and their joint influence with polygenic risk scores (PRSs) remains limited.&lt;h4>Methods&lt;/h4>The UK Biobank recruited 502,534 individuals ages 37 to 73 years living in the United Kingdom between 2006 and 2010. After quality control, genotype data from 459,855 individuals were available for CNV calling. A total of 61 commonly studied recurrent neuropsychiatric CNVs were selected for analyses and examined individually and in aggregate (any CNV, deletion, or duplication). CNV risk scores were used to quantify intolerance of CNVs to haploinsufficiency. Major depressive disorder and generalized anxiety disorder PRSs were generated for White British individuals (N = 408,870). Mood/anxiety factor s</pubmed_abstract><journal>Biological psychiatry</journal><pubmed_title>Impact of Copy Number Variants and Polygenic Risk Scores on Psychopathology in the UK Biobank.</pubmed_title><pmcid>PMC10409883</pmcid><funding_grant_id>U01 MH119690</funding_grant_id><funding_grant_id>U01 MH119739</funding_grant_id><funding_grant_id>P50 HD105351</funding_grant_id><funding_grant_id>U01-MH119690</funding_grant_id><pubmed_authors>Huguet G</pubmed_authors><pubmed_authors>Mathias SR</pubmed_authors><pubmed_authors>Rodrigue A</pubmed_authors><pubmed_authors>Saci Z</pubmed_authors><pubmed_authors>Almasy L</pubmed_authors><pubmed_authors>Jean-Louis M</pubmed_authors><pubmed_authors>Schultz LM</pubmed_authors><pubmed_authors>Mollon J</pubmed_authors><pubmed_authors>Kumar K</pubmed_authors><pubmed_authors>Alexander-Bloch A</pubmed_authors><pubmed_authors>Douard E</pubmed_authors><pubmed_authors>Knowles EEM</pubmed_authors><pubmed_authors>Glahn DC</pubmed_authors><pubmed_authors>Jacquemont S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Copy Number Variants and Polygenic Risk Scores on Psychopathology in the UK Biobank.</name><description>&lt;h4>Background&lt;/h4>Our understanding of the impact of copy number variants (CNVs) on psychopathology and their joint influence with polygenic risk scores (PRSs) remains limited.&lt;h4>Methods&lt;/h4>The UK Biobank recruited 502,534 individuals ages 37 to 73 years living in the United Kingdom between 2006 and 2010. After quality control, genotype data from 459,855 individuals were available for CNV calling. A total of 61 commonly studied recurrent neuropsychiatric CNVs were selected for analyses and examined individually and in aggregate (any CNV, deletion, or duplication). CNV risk scores were used to quantify intolerance of CNVs to haploinsufficiency. Major depressive disorder and generalized anxiety disorder PRSs were generated for White British individuals (N = 408,870). Mood/anxiety factor s</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T11:34:42.841Z</modification><creation>2025-04-04T11:34:42.841Z</creation></dates><accession>S-EPMC10409883</accession><cross_references><pubmed>36764568</pubmed><doi>10.1016/j.biopsych.2023.01.028</doi></cross_references></HashMap>